Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
BARAHONA-CORREA, Julián et al. Pulmonary involvement in Sjögren's syndrome. Rev.Colomb.Reumatol. [online]. 2020, vol.27, suppl.2, pp.109-124. Epub Sep 07, 2021. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2020.06.013.
Sjögren’s syndrome is a systemic autoimmune disease with a high burden for the individual, as well as society. Pulmonary compromise presents with a myriad of manifestations that influence patient quality of life and mortality risk. An integrated dynamic approach by a multidisciplinary diagnostic discussion team that includes experts in chest diseases, rheumatology, radiology, and pathology has the potential to improve the identification, management strategies, and outcomes. Although early recognition of patients at high risk is essential, there is currently a lack of reliable biomarkers. Pharmacological therapies are based on immunomodulation, although the evidence to support their use is of low quality. Increasing awareness and training among healthcare professionals may reduce a delayed access to specialized assessment.
Keywords : Sjögren’s syndrome; Respiratory system; Lung; Interstitial lung diseases; Interdisciplinary communication.